Cat’s Whiskers for Urinary Tract Complaints

Cat’s whiskers — Orthosiphon aristatus, still filed under Orthosiphon stamineus in most of the research literature, and known as misai kucing, kumis kucing or java tea depending on where you buy it — carries a European licence for “flushing of the urinary tract.” Shops read that phrase as though it said “urinary infection.” It does not, and the gap between those two things is what this page is about.

The distinction matters more here than almost anywhere else on this site, because urinary symptoms are common, unpleasant, and one of the situations where people most often reach for a herb rather than a diagnosis. A bladder infection left to run can climb to the kidney. So this page does three things: it states exactly what the flushing indication covers, it examines the entire antibacterial evidence base for this plant (which is smaller than most readers expect), and it spends real space on the two questions that actually change outcomes — when urinary symptoms are not an infection, and when they are an emergency.

Table of Contents

1. What “Flushing” Actually Licenses
2. The Entire Antibacterial Evidence Base
3. Does Anything Active Even Reach the Urine?
4. Absent Versus Negative: How This Differs From Uva Ursi
5. Why Delay Is Not a Neutral Choice
6. Red Flags: Stop and Get Seen
7. When Urinary Symptoms Are Not an Infection
8. Asymptomatic Bacteriuria: Where Doing Less Is Right
9. Recurrent Infection: What Has Evidence
10. What a Real Urinary Trial Would Measure
11. Where Java Tea Legitimately Fits
12. Evidence Ledger for This Page
13. Key Research Papers
14. Connections

What “Flushing” Actually Licenses

The European Union herbal monograph on Orthosiphon aristatus leaf registers it as a traditional herbal medicinal product “used to increase the amount of urine to achieve flushing of the urinary tract as an adjuvant in minor urinary tract complaints.”

Four qualifiers are doing work in that sentence, and every one of them is dropped in marketing.

1. “Increase the amount of urine” is the mechanism claimed — volume, not killing anything.
2. “Flushing” is a physical description, not a clinical outcome. Nothing in the registration says flushing shortens an illness.
3. “Adjuvant” means alongside something else. A licence that calls a product an adjuvant is explicitly declining to call it a treatment.
4. “Minor” excludes anything with fever, pain on passing urine, spasm or blood — and the monograph names all four as reasons to stop and see a clinician.

The registration itself rests on a legal category rather than on trials. Traditional-use registration in Europe requires thirty years of documented medicinal use, fifteen of them in the EU, plus pharmacological plausibility and acceptable safety — and explicitly no efficacy data. The monograph’s “well-established use” column, the one that does require clinical evidence, is empty for this herb. Every dose, indication and contraindication sits in the traditional column. The instrument is being read correctly only when you can say all of the following in one breath: this is licensed in Europe, it has been used for a very long time, it appears safe, and no trial shows it works. The main cat’s whiskers page reproduces the monograph text.

The Entire Antibacterial Evidence Base

People assume a urinary herb is a urinary antiseptic. For this plant that assumption has almost nothing behind it, and the most-cited study is not what it appears to be.

The catheter study, dissected. The paper usually offered is Solidago, orthosiphon, birch and cranberry extracts can decrease microbial colonization and biofilm development in indwelling urinary catheter: a microbiologic and ultrastructural pilot study, in World Journal of Urology, 2014 — PubMed search. It is genuinely interesting work. It is also, as evidence for cat’s whiskers, compromised in three separate ways at once:

• Formula substitution. The preparation contained four plants: goldenrod (Solidago), orthosiphon, birch and cranberry. Cranberry has its own long literature on bacterial adhesion, and goldenrod carries its own European urinary registration. There is no way to assign any part of the result to Orthosiphon. A product whose stated purpose is to combine complementary actions is the worst possible source for a single-ingredient claim.
• Surface substitution. The outcome measured was colonisation and biofilm on catheter material, assessed microbiologically and by electron microscopy. A silicone or latex device surface in the bladder is not bladder urothelium, and biofilm on a foreign body is a different biological problem from an infection of living tissue.
• Endpoint substitution. It reported colonisation, not illness. No symptom score, no cure rate, no antibiotic use, no episodes of infection prevented.

None of that makes it a bad study — it was published as a pilot and described as one. It makes it the wrong study to quote as evidence that java tea fights urinary infection, which is how it is invariably quoted.

The laboratory literature. Extracts of Orthosiphon do inhibit bacteria in a dish, as extracts of most polyphenol-rich plants do; see PubMed: Orthosiphon stamineus antibacterial activity in vitro. Petri-dish activity is a starting hypothesis and nothing more. The relevant question is never “does it inhibit E. coli in a well?” but “does anything reaching human urine do so at an inhibitory concentration?” — which is the next section.

The human literature. There is no randomised trial of cat’s whiskers as a treatment for urinary tract infection. Not a negative one, not a positive one, not a small one. The claim has never been tested.

Does Anything Active Even Reach the Urine?

A urinary antiseptic has a specific requirement that a general antibacterial does not: the active compound has to be excreted in urine, intact and concentrated. That is a real and answerable pharmacokinetic question, and for this plant it is unanswered.

What we know points to difficulty rather than promise. The marker flavones — sinensetin, eupatorin and 3′-hydroxy-5,6,7,4′-tetramethoxyflavone — are polymethoxylated and therefore lipophilic and poorly water-soluble, which is unhelpful both for extraction into a tea and for renal excretion; lipophilic compounds tend to be reabsorbed in the tubule rather than excreted. Rosmarinic acid and related caffeic-acid depsides are better absorbed but are extensively conjugated, and work on pig gut microbiota metabolising Orthosiphon aristatus extract found substantial bacterial transformation before absorption — PubMed search. The molecules in the urine are therefore not the molecules on the certificate of analysis, and nobody has published what they are or at what concentration.

We are not going to compute a minimum-inhibitory-concentration gap for this herb, and it is worth saying why we refuse. Doing that arithmetic honestly requires two numbers: a measured MIC against a urinary pathogen for a defined preparation, and a measured urinary concentration of the same material in humans. The second does not exist for cat’s whiskers. Any “it reaches antibacterial levels in urine” claim you encounter is therefore a guess dressed as pharmacokinetics, whichever direction it points.

Contrast uva ursi, where the mechanism is at least fully articulated: arbutin is absorbed, conjugated, excreted in urine as hydroquinone conjugates, and hydroquinone is liberated locally where bacteria are. That is a coherent, specific urinary-delivery story — and it is why bearberry, not java tea, was the herb somebody thought worth putting into a randomised trial.

Absent Versus Negative: How This Differs From Uva Ursi

Two verdicts get collapsed into “the evidence is weak,” and keeping them apart is more useful than any hedge.

• Uva ursi: NEGATIVE. Bearberry leaf was tested against placebo in women with uncomplicated urinary infection in ordinary general practice and did not shorten symptoms. In a second trial it was tested against a single antibiotic dose and produced a higher symptom burden and more kidney infections. Those are results, and they point the wrong way. The full account is on the uva ursi trials page.
• Cat’s whiskers: ABSENT. No adequate trial has been run at all. There is no negative result, and no positive one.

Both directions of misreading are wrong. “Absent” is not exoneration — an untested claim is not a supported claim, and the fact that java tea escaped a bad result only means it escaped the test. But “absent” is also not the same as refuted, and it would be unfair to write as though this herb had failed a trial it never had.

There is one uncomfortable inference the reader deserves. The herb with the better mechanistic story, an explicit urinary-delivery route and a defined active moiety was trialled, and it lost. Cat’s whiskers has a vaguer story, no established urinary delivery, and no trial. That is not a reason to expect it to do better.

Why Delay Is Not a Neutral Choice

This site has set out the argument in full on the uva ursi page, and rather than re-derive it here, the short version and the link.

A simple bladder infection is bacteria multiplying in the bladder lining. Pyelonephritis is the same bacteria having travelled up the ureters into the kidney: high fever, shaking chills, flank pain, vomiting, and a real risk of the infection reaching the bloodstream. It commonly needs intravenous antibiotics, sometimes admission, and in a minority leaves lasting kidney scarring. See Pyelonephritis.

The arithmetic of waiting is therefore asymmetric. The upside of avoiding an antibiotic course is real but modest. The downside is uncommon but severe. Across several randomised trials of non-antibiotic strategies for uncomplicated cystitis — using anti-inflammatories rather than herbs — the pattern repeats: fewer prescriptions, more symptom-days, and consistently more upper urinary tract infections in the non-antibiotic arm. Individually those counts are small enough to shrug at; repeated across independent trials in different countries, they stop being noise.

Antibiotic overuse is a genuine problem, and none of this says otherwise. The answer to it is better diagnosis, shorter targeted courses and, where appropriate, non-antibiotic prophylaxis with evidence behind it — decided with a clinician, not substituted at home with an untested tea.

Red Flags: Stop and Get Seen

This list is the most important thing on the page and is deliberately consistent with the one on the uva ursi page. If any of it applies, herbs are not the question.

• Fever, chills, or feeling systemically unwell. Simple cystitis does not usually cause fever. Fever suggests the kidney.
• Flank or back pain, often one-sided, sometimes tender when tapped.
• Nausea or vomiting — both point upward from the bladder, and vomiting also means you cannot reliably keep a drink down.
• Blood in the urine. Visible blood needs evaluation even when infection is the likely cause. See Urinalysis.
• Pregnancy. Urinary infection in pregnancy is treated promptly, and this herb is not recommended in pregnancy for lack of data.
• Male sex. Urinary infection in men is not classed as uncomplicated and warrants assessment for prostate or structural involvement. See Prostatitis.
• Children. Assessment is needed, and the monograph does not recommend this herb under 18 at all.
• No improvement within 48 hours, or worsening at any point.
• Diabetes, immune suppression, kidney disease, a urinary catheter, a known structural abnormality, or a recent urological procedure. All move an episode out of the “simple” category. See Kidney Disease.
• Confusion or new unsteadiness in an older adult, which can be how infection presents instead of burning.
• Anything the monograph itself names — fever, painful urination, spasms, blood — and any symptoms lasting beyond two weeks.

When Urinary Symptoms Are Not an Infection

This section may be the most practically useful on the page, because a large share of people self-treating “a UTI” do not have one. Symptoms alone misclassify a meaningful proportion of episodes, which is why a dipstick and culture are worth the trouble. Common alternatives:

• Overactive bladder — urgency and frequency without infection, driven by detrusor overactivity. Antibiotics do nothing; bladder training and specific drugs do. See Overactive Bladder.
• Interstitial cystitis / bladder pain syndrome — a chronically irritated bladder lining with sterile urine. Repeated antibiotic courses are a common and unhelpful pattern here. See Interstitial Cystitis.
• Benign prostatic enlargement in men — hesitancy, weak stream, frequency, incomplete emptying. A diuretic tea makes frequency worse and treats nothing. See Benign Prostatic Hyperplasia.
• Prostatitis — pelvic pain with urinary symptoms, acute or chronic, and managed quite differently from cystitis. See Prostatitis.
• Genitourinary syndrome of menopause — thinning of vaginal and urethral tissue after menopause causes burning, urgency and genuinely recurrent infections. Local oestrogen addresses the cause; tea does not.
• Sexually transmitted infection — chlamydial or gonococcal urethritis is regularly mistaken for cystitis, and needs specific treatment and partner notification.
• Uncontrolled diabetes — high blood glucose spills into urine and causes frequency and thirst that feel like a bladder problem. Drinking more herbal tea for it is treating a symptom of something serious.
• Stones and obstruction — covered on the diuretic and stones page.
• Bladder cancer — painless visible blood in the urine, particularly in an older smoker, is a red flag until proven otherwise. See Bladder Cancer.

Note what this list implies about the licensed indication. “Minor urinary tract complaints” is a broad category that includes several of the above, and a mild pleasant diuretic drink is an entirely reasonable thing to have in it — provided the diagnosis has been made rather than assumed.

Asymptomatic Bacteriuria: Where Doing Less Is Right

Bacteria in the urine without symptoms is common, especially in older adults, in people with catheters and in pregnancy. Outside two specific situations — pregnancy, and before an invasive urological procedure — treating it does not help and does cause harm: side effects, resistance and Clostridioides difficile. Major guidance has been consistent about this for years; see PubMed: management of asymptomatic bacteriuria, guideline.

Why does that belong on a herb page? Because a positive dipstick with no symptoms is a classic trigger for someone to start a “flushing” tea. In that scenario the tea is being taken for a condition that does not require treatment, which means any subsequent “improvement” is guaranteed and meaningless. It is a small illustration of a general rule: an intervention aimed at a non-disease always appears to work.

Recurrent Infection: What Has Evidence

Recurrent cystitis is where people reach hardest for herbs, so it deserves an honest list of what actually has human evidence behind it.

• Drinking more water. A randomised trial in premenopausal women with recurrent urinary infection, published in JAMA Internal Medicine in 2018, found fewer episodes with increased daily water intake — PubMed search. This is worth pausing on, because it is the mechanism java tea is licensed for — and it has been demonstrated with plain water. If flushing helps, water already provides it.
• Methenamine hippurate. The ALTAR trial, an open-label randomised non-inferiority study published in the BMJ in 2022, found methenamine non-inferior to daily antibiotic prophylaxis in women with recurrent infection — PubMed search. This is the strongest genuine antibiotic-sparing option in the field, and notably it is a urinary antiseptic with a defined mechanism that requires acidic urine.
• Cranberry for prevention. Cochrane reviews have repeatedly assessed cranberry products for preventing recurrence and find a modest reduction in some groups — PubMed search. Prevention, not treatment. See Cranberries.
• Vaginal oestrogen after menopause, addressing the tissue change that drives recurrence in that group.
• Reviewing contraception, treating constipation, and post-coital prophylaxis in selected cases.

There is a quiet irony worth flagging. Methenamine works only in acidic urine, while a potassium-rich plant infusion would tend to push urine in the alkaline direction — and the traditional requirement for uva ursi runs the other way again, needing alkaline urine. Nobody has studied whether java tea affects methenamine, and we are not going to claim an interaction on theory alone. But if you are prescribed methenamine, mention the tea to whoever prescribed it.

What a Real Urinary Trial Would Measure

“You cannot trial a traditional herb” is untrue here in the most concrete possible way: this exact trial has been run twice, on a different plant. The template exists. A competent trial of cat’s whiskers in urinary complaints would report:

1. Symptom burden on a validated instrument, recorded daily — frequency, urgency, dysuria and suprapubic pain, summed over the first week.
2. Time to symptom resolution, against placebo, in participants with a positive culture at baseline.
3. Bacteriological cure on midstream culture at around day seven.
4. Antibiotic use over the following two weeks — the outcome an antibiotic-sparing strategy exists to change.
5. Incidence of pyelonephritis, pre-specified and reported however small, because that is the harm the strategy risks.
6. Recurrence at six months, for any prevention claim.
7. Urine volume and urinary electrolytes, to demonstrate that the licensed mechanism — flushing — actually occurred.

The last item is the interesting one, and it is missing even from the trials of other urinary herbs. A flushing product should be required to demonstrate flushing. If it does not increase urine volume beyond an equal-volume control, its own proposed mechanism has failed, and no clinical endpoint is needed to conclude that.

Where Java Tea Legitimately Fits

Nothing above says do not drink it. It says be accurate about what it is. A defensible position looks like this:

1. As a pleasant way to drink more fluid, it is fine, and increased fluid intake has genuine randomised evidence in recurrent cystitis and in stone prevention. Credit belongs to the water, but the water still counts.
2. As an adjuvant in minor complaints, in adults, for up to two weeks, it sits exactly where its licence puts it — provided a diagnosis has been made and no red flag is present.
3. Not as a treatment for a diagnosed infection, and not as a reason to postpone assessment.
4. Not while a fever, flank pain or visible blood is present.
5. Not at all in the groups listed on the safety page — advanced kidney disease, heart failure or any condition where fluid intake is deliberately restricted, and with care alongside prescription diuretics, ACE inhibitors, ARBs and lithium.

That is a smaller claim than the one on the packet. It is also one that will not get anybody hurt, and it is the only version the evidence supports.

Evidence Ledger for This Page

1. Regulatory, correctly read. European traditional-use registration for increasing urine volume to flush the urinary tract, as an adjuvant, in minor complaints, in adults, for up to two weeks. No efficacy demonstrated or claimed.
2. Absent. Any randomised trial of cat’s whiskers for urinary tract infection — treatment or prevention. None exists in either direction.
3. Absent. Any human pharmacokinetic study establishing that an antibacterial constituent reaches urine at an inhibitory concentration.
4. Preliminary, and thrice-removed. A four-herb combination reduced colonisation and biofilm on catheter material in a pilot study — wrong number of plants, wrong surface, wrong endpoint for the claim it is used to support.
5. Preliminary (in vitro). Orthosiphon extracts inhibit bacteria in culture, as most polyphenol-rich plant extracts do.
6. Established, and about the water. Increased daily water intake reduced recurrence in a randomised trial — the licensed mechanism, demonstrated without the herb.
7. Established, elsewhere. Methenamine hippurate non-inferior to antibiotic prophylaxis; cranberry modestly effective for prevention; treating asymptomatic bacteriuria harmful outside pregnancy and pre-procedure.
8. Negative, on a neighbouring herb. Uva ursi failed against placebo and produced more pyelonephritis than a single antibiotic dose. Relevant as calibration, not as a result about this plant.
9. Traditional use only. “Urinary antiseptic,” cleansing, difficult urination.
10. Refused. Any minimum-inhibitory-concentration comparison for this herb, because the human urinary concentration needed to compute it has never been measured; and any claimed interaction with methenamine, which is mechanism-level speculation and nothing more.

Key Research Papers

Citations are PubMed topic searches, with title, journal and year given in prose so a link can never resolve to the wrong paper.

1. Solidago, orthosiphon, birch and cranberry extracts can decrease microbial colonization and biofilm development in indwelling urinary catheter: a microbiologic and ultrastructural pilot study. World Journal of Urology, 2014. The four-herb catheter pilot. PubMed search
2. Gut microbiota of pigs metabolizes extracts of Filipendula ulmaria and Orthosiphon aristatus — herbal remedies used in urinary tract disorders. Planta Medica, 2022. Bacterial transformation before absorption. PubMed search
3. Uva-ursi extract and ibuprofen as alternative treatments for uncomplicated urinary tract infection in women (ATAFUTI): a factorial randomized trial. Clinical Microbiology and Infection, 2019. The placebo-controlled trial on the neighbouring herb. PubMed search
4. Herbal treatment with uva ursi extract versus fosfomycin in women with uncomplicated urinary tract infection in primary care: a randomized controlled trial. Clinical Microbiology and Infection, 2021 (REGATTA). More symptom-days and more pyelonephritis in the herbal arm. PubMed search
5. Effect of increased daily water intake in premenopausal women with recurrent urinary tract infections: a randomized clinical trial. JAMA Internal Medicine, 2018. Flushing, demonstrated with plain water. PubMed search
6. Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trial. BMJ, 2022 (ALTAR). Methenamine hippurate as a genuine antibiotic-sparing option. PubMed search
7. Cranberries for preventing urinary tract infections. Cochrane Database of Systematic Reviews. Prevention, modest, better evidenced than any of the herbs here. PubMed search
8. Guideline — management of asymptomatic bacteriuria, including who should and should not be treated. PubMed search
9. The diagnosis of urinary tract infection: a systematic review. Why symptoms alone misclassify a meaningful share of episodes. PubMed search
10. Topic search — Orthosiphon stamineus antibacterial activity in vitro. The whole laboratory antibacterial literature for this plant.
11. Topic search — Orthosiphon aristatus and the urinary tract, and its synonym Orthosiphon stamineus and urinary — run both, because the literature is split across the two names.
12. Topic search — delayed antibiotics and pyelonephritis risk in uncomplicated UTI. The evidence behind the delay argument.

Connections

• All Herbs
• Cat’s Whiskers / Java Tea — the main page, with the monograph wording and dose table.
• Diuretic and Kidney Stone Claims — the flushing mechanism, and why the mug does most of the work.
• Kidney Cautions and Interactions — who should not drink this, and why.
• Metabolic and Blood Pressure Research — the rest of the research file.
• Urinary Tract Infections — diagnosis, treatment, and what “uncomplicated” means.
• Pyelonephritis — what an infection that reaches the kidney actually does.
• Interstitial Cystitis — bladder pain with sterile urine, often mistaken for infection.
• Overactive Bladder — urgency and frequency without infection.
• Benign Prostatic Hyperplasia — the commonest non-infective cause of urinary symptoms in men.
• Prostatitis — why urinary infection in men is never “uncomplicated.”
• Uva Ursi: What the Trials Found — the negative-result page this one is calibrated against.
• Uva Ursi Benefits — mechanism, dosing limits and the hydroquinone ceiling.
• Cleavers as a Diuretic — the same flushing tradition in a European plant.
• Horsetail for Urinary Health — another traditional aquaretic with an EU registration.
• Cranberries — the prevention comparator with real trial data.
• Urinalysis — the dipstick and culture that settle whether this is an infection at all.

Back to Table of Contents